Lithium Controlled-Release and Extended-Release Tablets and Octreotide injection
Determining the interaction of Lithium Controlled-Release and Extended-Release Tablets and Octreotide injection and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: lithium
Brand name: Lithobid, Eskalith, Lithonate, Lithotabs, Eskalith-CR
Synonyms: Lithium
Generic Name: octreotide
Brand name: Sandostatin, Sandostatin LAR Depot
Synonyms: Octreotide (injection), Octreotide
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Lithium Controlled-Release and Extended-Release Tablets-Octreotide Injection, Intramuscular
- Lithium Controlled-Release and Extended-Release Tablets-Octreotide Long-Acting Injection
- Lithium Controlled-Release and Extended-Release Tablets-Ocu-Carpine
- Lithium Controlled-Release and Extended-Release Tablets-Ocu-Chlor
- Lithium Controlled-Release and Extended-Release Tablets-Ocu-Dex
- Lithium Controlled-Release and Extended-Release Tablets-Ocu-Disal
- Octreotide injection-Lithium ER
- Octreotide injection-Lithium Oral Solution
- Octreotide injection-Lithium Salts
- Octreotide injection-Lithium Syrup and Oral Solution
- Octreotide injection-Lithobid
- Octreotide injection-Lithostat